デフォルト表紙
市場調査レポート
商品コード
1479070

管腔内縫合器の世界市場の評価:製品別、コンポーネント別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)

Endoluminal Suturing Devices Market Assessment, By Product, By Component, By Application, By End-User, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 234 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
管腔内縫合器の世界市場の評価:製品別、コンポーネント別、用途別、エンドユーザー別、地域別、機会、予測(2017年~2031年)
出版日: 2024年05月14日
発行: Market Xcel - Markets and Data
ページ情報: 英文 234 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の管腔内縫合器の市場規模は、2023年の9,128万米ドルから2031年に1億9,638万米ドルに達すると予測され、予測期間の2024年~2031年にCAGRで10.05%の成長が見込まれます。市場の拡大は、非侵襲手術への選好の高まり、消化器がんの有病率の増加、医療部門の拡大によって支えられています。

慢性疾患の有病率の増加は、世界の管腔内縫合器市場の主要動向の1つです。この増加は、管腔内縫合器が胃腸手術、肥満手術、胃食道逆流症、胸部手術、泌尿器科手術などで重要な役割を果たすことから、管腔内縫合器を含むさまざまな効率的な手術ソリューションへの要求を後押ししています。肥満手術では、これらの機器は胃バイパスや胃スリーブなどのさまざまな手技を行うために展開され、体重の減少を達成することで肥満関連の合併症を管理する患者を支援します。これらの機器に対する選好の高まりは、低侵襲で健康状態を治療し、より早い回復を提供し、手術リスクを低減し、患者の生活の質を向上させる能力もその一因であると考えられます。

医療システムの効率と費用対効果を高めることが重視されるようになり、市場に有利な成長機会がもたらされています。管腔内縫合器は、医療提供者がリソースを最適化しながら、長期入院に伴うコストを削減するのに役立ちます。消化器疾患の患者の増加が、管腔内縫合器への要求をさらに高めています。2022年7月から2023年5月に実施されたアンケート調査によると、海南省では機能性胃腸疾患の有病率は32%でした。医療インフラの強化に向けた投資の増加や急速な人口拡大も、世界の管腔内縫合器の市場規模を押し上げる大きな要因となっています。

低侵襲手術への選好の高まりが市場拡大を支える

低侵襲手術に関連するさまざまな利点に対する認識の高まりにより、低侵襲手術への選好が高まっていることが、市場の拡大にプラスの影響を与えています。低侵襲手術は、合併症の減少、痛みの軽減、入院期間の短縮につながります。これらの機器は、外科医が解剖学的に困難な場所や体腔内で正確な縫合を行う際に役立ちます。この機器が提供する高い操作性と制御性により、外科医はさらに最適な手術結果を得ることができます。また、回復時間の短縮、感染リスクの低減、患者の満足度の向上にもつながります。管腔内縫合器はまた、外科医が組織を内部で縫合できるようにすることで、大きな切開の必要性をなくします。そのため需要が促進され、市場拡大にプラスの影響を与えます。

技術の進歩が世界の管腔内縫合器市場を押し上げる

管腔内縫合器が提供する機能性、使いやすさ、精度の向上を支援する研究開発の高まりが、市場の成長を促進しています。ロボット技術の活用は、人間工学に基づいた直感的な操作とともに、器用で正確な動作を外科医に提供します。手術中の低侵襲性への選好の高まりは、ロボット工学の技術の進歩と相まって、柔軟な手術ロボットの登場を支えています。さらに、内視鏡や透視などの画像技術を取り入れることで、縫合プロセス中の手術結果を改善するリアルタイムの視覚化が可能になります。技術の進歩は、データ管理機能や無線接続機能を備えた先進の管腔内縫合器の開発を支援し、手術指標や機器パラメーターのリアルタイムモニタリングを可能にするため、市場に有利な成長機会を提供します。

さまざまな主要市場企業による研究開発への投資の活発化も、先進技術を利用した管腔内縫合器の開発を後押ししています。2022年、Boston Scientificはプネに最先端の研究開発センターを開設しました。同センターは、内視鏡、泌尿器、心臓病、神経調節など、多様な分野の専門知識を提供します。

北米が市場で大きなシェアを占める

北米の管腔内縫合器市場の成長を支えている要因は、確立された医療インフラのプレゼンス、外科手術に対するニーズの高まり、さまざまな主要市場企業の強力な配置などです。同地域の市場成長は、有利な償還政策の導入や大規模な患者人口の利用可能性にも起因しています。また、カナダや米国などでは、低侵襲手術の需要が高まっています。低侵襲手術は、感染、出血、瘢痕形成、回復にかかる時間などのリスクを軽減するためです。管腔内縫合器は、外科医がより小さな切開で縫合を行うことを可能にし、このような手術において不可欠な役割を果たしています。同地域における肥満治療件数の増加が、北米市場の拡大をさらに後押ししています。American Society for Metabolic and Bariatric Surgeryの推計によると、2022年に実施された肥満手術の総数は27万9,967件でした。

当レポートでは、世界の管腔内縫合器市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の管腔内縫合器市場の見通し(2017年~2031年)

  • 市場規模と予測
    • 金額
    • 数量
  • 製品別
    • 血管内縫合器
    • 内視鏡縫合器
    • 消耗品
  • コンポーネント別
    • カニューレ
    • 吸引ポート
  • 用途別
    • 消化器手術
    • 肥満手術
    • 胃食道逆流症
    • 胸部手術
    • 泌尿器科手術
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • 診療所
    • その他
  • 地域別
    • 北米
    • 南米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア:企業別(2023年)

第5章 世界の管腔内縫合器市場の見通し:地域別(2017年~2031年)

  • 北米
    • 市場規模と予測
    • 製品別
    • コンポーネント別
    • 用途別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第6章 市場マッピング(2023年)

  • 製品別
  • コンポーネント別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸入輸出分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因(課題、抑制要因)

第9章 規制枠組みとイノベーション

  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第10章 主要企業の情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析(2023年)
  • 合併と買収/合弁事業(該当する場合)
  • SWOT分析(市場企業5社)
  • 特許分析(該当する場合)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Apollo Endosurgery, Inc. (Boston Scientific Corporation)
  • Products and Services
  • B. Braun SE
  • Medtronic plc
  • Johnson & Johnson
  • Cook Medical
  • Endo Tools Therapeutics S.A.
  • USGI, Medical, Inc.
  • Stryker Corporation
  • Ovesco Endoscopy AG
  • ErgoSuture

第14章 戦略的推奨

第15章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 2.Global Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 4.Global Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 5.Global Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 6.Global Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 7.Global Endoluminal Suturing Devices Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 9.North America Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 11.North America Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 12.North America Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 13.North America Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 14.North America Endoluminal Suturing Devices Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 16.United States Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 18.United States Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 19.United States Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 20.United States Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 21.Canada Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 22.Canada Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 24.Canada Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 25.Canada Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 26.Canada Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 27.Mexico Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 28.Mexico Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 30.Mexico Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 31.Mexico Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 32.Mexico Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 33.Europe Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 34.Europe Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 36.Europe Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 37.Europe Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 38.Europe Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 39.Europe Endoluminal Suturing Devices Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 41.Germany Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 43.Germany Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 44.Germany Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 45.Germany Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 46.France Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 47.France Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 49.France Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 50.France Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 51.France Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 52.Italy Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 53.Italy Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 55.Italy Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 56.Italy Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 57.Italy Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 58.United Kingdom Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 59.United Kingdom Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 61.United Kingdom Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 62.United Kingdom Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 63.United Kingdom Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 64.Russia Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 65.Russia Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 67.Russia Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 68.Russia Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 69.Russia Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 70.Netherlands Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 71.Netherlands Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 73.Netherlands Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 74.Netherlands Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 75.Netherlands Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 76.Spain Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 77.Spain Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 79.Spain Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 80.Spain Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 81.Spain Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 82.Turkey Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 83.Turkey Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 85.Turkey Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 86.Turkey Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 87.Turkey Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 88.Poland Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 89.Poland Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 91.Poland Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 92.Poland Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 93.Poland Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 94.South America Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 95.South America Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 97.South America Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 98.South America Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 99.South America Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 100.South America Endoluminal Suturing Devices Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 102.Brazil Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 104.Brazil Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 105.Brazil Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 106.Brazil Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 107.Argentina Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 108.Argentina Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 110.Argentina Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 111.Argentina Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 112.Argentina Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 113.Asia-Pacific Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 114.Asia-Pacific Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 116.Asia-Pacific Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 117.Asia-Pacific Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 118.Asia-Pacific Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 119.Asia-Pacific Endoluminal Suturing Devices Market Share (%), By Country, 2017-2031F
  • Figure 120.India Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 121.India Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 123.India Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 124.India Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 125.India Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 126.China Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 127.China Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 129.China Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 130.China Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 131.China Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 132.Japan Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 133.Japan Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 135.Japan Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 136.Japan Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 137.Japan Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 138.Australia Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 139.Australia Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 141.Australia Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 142.Australia Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 143.Australia Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 144.Vietnam Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 145.Vietnam Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 147.Vietnam Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 148.Vietnam Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 149.Vietnam Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 150.South Korea Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 151.South Korea Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 153.South Korea Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 154.South Korea Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 155.South Korea Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 156.Indonesia Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 157.Indonesia Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 159.Indonesia Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 160.Indonesia Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 161.Indonesia Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 162.Philippines Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 163.Philippines Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 165.Philippines Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 166.Philippines Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 167.Philippines Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 168.Middle East & Africa Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 169.Middle East & Africa Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 171.Middle East & Africa Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 172.Middle East & Africa Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 173.Middle East & Africa Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 174.Middle East & Africa Endoluminal Suturing Devices Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 176.Saudi Arabia Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 178.Saudi Arabia Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 179.Saudi Arabia Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 180.Saudi Arabia Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 181.UAE Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 182.UAE Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 184.UAE Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 185.UAE Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 186.UAE Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 187.South Africa Endoluminal Suturing Devices Market, By Value, In USD Million, 2017-2031F
  • Figure 188.South Africa Endoluminal Suturing Devices Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Endoluminal Suturing Devices Market Share (%), By Product, 2017-2031F
  • Figure 190.South Africa Endoluminal Suturing Devices Market Share (%), By Component, 2017-2031F
  • Figure 191.South Africa Endoluminal Suturing Devices Market Share (%), By Application, 2017-2031F
  • Figure 192.South Africa Endoluminal Suturing Devices Market Share (%), By End-User, 2017-2031F
  • Figure 193.By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 194.By Component Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 195.By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 196.By End-User Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
目次
Product Code: MX11321

Global endoluminal suturing devices market is projected to witness a CAGR of 10.05% during the forecast period 2024-2031, growing from USD 91.28 million in 2023 to USD 196.38 million in 2031F. The expansion of the market is supported by the increase in preference for non-invasive surgical procedures, growth in prevalence of gastrointestinal cancer, and the expansion of the healthcare sector.

The increasing prevalence of chronic diseases is one of the major global endoluminal suturing devices market trends. This increase is propelling the requirement for various efficient surgical solutions, including endoluminal suturing devices, as they play a crucial role in gastrointestinal surgeries, bariatric surgeries, gastroesophageal reflux disease, thoracic procedures, and urological procedures, among others. In bariatric surgery, these devices are deployed for performing different procedures, including gastric bypass and gastric sleeve, aiding patients in managing obesity-related comorbidities by achieving weight loss. The increased preference for these devices can also be attributed to their ability to treat the health condition in a minimally invasive manner, provide faster recovery and reduce surgical risks and improving the quality of life of the patient.

The rising emphasis on increasing the efficiency and cost-effectiveness of healthcare systems is providing lucrative growth opportunities for the market. Endoluminal suturing devices aid healthcare providers in reducing costs associated with extended hospital stays while allowing them to optimize resources. The growing number of cases of gastrointestinal disorders is further boosting the requirement for endoluminal suturing devices. According to a questionnaire survey conducted from July 2022 to May 2023, in Hainan, the prevalence of functional gastrointestinal diseases was 32%. The growing investments towards the enhancement of healthcare infrastructure and rapid population expansion are other major factors boosting the global endoluminal suturing devices market size.

Increasing Preference for Minimally Invasive Procedures Supports Market Expansion

The rising preference for minimally invasive procedures due to growing awareness about the various advantages associated with them is positively influencing the expansion of the market. Minimally invasive procedures are linked with fewer complications, less pain, and shorter hospitalizations. These devices aid surgeons in performing precise suturing in anatomically challenging locations and body cavities. The greater maneuverability and control offered by the devices further allow surgeons to achieve optimal surgical outcomes. The devices are also associated with faster recovery times, reduced risk of infection, and improved patient satisfaction. Endoluminal suturing devices also eliminate the requirement for large incisions by allowing surgeons to suture tissues internally, thus boosting their demand and positively influencing market expansion.

Technological Advancements Boost Global Endoluminal Suturing Devices Market

The increasing research and development efforts to support the enhancement of the functionality, ease of use, and precision offered by endoluminal suturing devices are driving the growth of the market. The utilization of robotic technology provides surgeons with dexterous and precise motions along with ergonomic and intuitive manipulation. The increased preference for minimal invasiveness during surgeries, coupled with technological advancements in robotics, has supported the emergence of flexible surgical robots. Additionally, the incorporation of imaging technologies, such as endoscopy and fluoroscopy, provides real-time visualization that improves procedural outcomes during the suturing process. Technological advancements will support the development of advanced endoluminal suturing devices that will feature data management capabilities and wireless connectivity, allowing the real-time monitoring of surgical metrics and device parameters, thus providing lucrative growth opportunities to the market.

The rising investments by various key market players in research and development will also support the development of technologically advanced endoluminal suturing devices. In 2022, Boston Scientific launched a state-of-the-art research and development center in Pune. The center provides expertise in diverse areas, including endoscopy, urology, cardiology, and neuromodulation, among others.

North America Holds Significant Share of the Market

The presence of a well-established healthcare infrastructure, the increasing requirement for surgical procedures, and the strong placement of various leading market players are some of the factors supporting the growth of the North America endoluminal suturing devices market. The growth of the market in the region can also be attributed to the introduction of favorable reimbursement policies and the availability of a large patient pool. The demand for minimally invasive procedures is also increasing in countries such as Canada and the United States, as they reduce the risk of infection, blood loss, scarring, and time of recovery. Endoluminal suturing devices allow surgeons to internally perform suturing with smaller incisions, playing an essential role in such procedures. The rise in the number of bariatric procedures in the region is further boosting the expansion of the market in North America. According to the estimates of the American Society for Metabolic and Bariatric Surgery, the total number of bariatric surgeries conducted in 2022 was 279,967.

Gastrointestinal Surgery Dominates the Market

The rising requirement for gastrointestinal surgeries can be attributed to the increasing occurrence of gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. According to the estimates of the International Agency for Research on Cancer, gastrointestinal cancer accounts for one in three cancer related deaths and one in four cancer cases across the globe.

Gastrointestinal perforations occur because of surgical complications, ulcers, and trauma. The endoluminal suturing devices are used for closing these perforations in order to prevent the leakage of gastric contents in the abdominal cavity. Therefore, the availability of effective endoluminal suturing devices is essential for the proper management of gastrointestinal perforations. Endoluminal suturing devices also allow surgeons to endoscopically close leaks that can occur at the site of anastomosis after gastrointestinal surgeries, avoiding the requirement for additional invasive surgeries.

Hospitals Account for a Significant Global Endoluminal Suturing Devices Market Share

The segment expansion is supported by the increased requirement for surgical procedures in various regions across the globe. The rising demand for surgical procedures can be attributed to the growing prevalence of chronic health diseases that require surgical procedures for further exploration of the condition in order to give an appropriate diagnosis. These procedures also help in treating various pathological conditions, such as malignancy, trauma, and injury. The rising investments by various hospitals to meet evolving patient requirements and provide advanced medical care is another major factor bolstering the demand for endoluminal suturing devices from hospitals. In April 2024, the construction of UCSF Health Helen Diller Hospital was initiated. The hospital is expected to cost USD 4.3 billion and will have 15 stories. The design of this new hospital will integrate care and advanced science to provide a healing habitat for the patients. The facility will have the latest technologies in diagnostics, robotics, and surgical procedures. The construction of such state-of-the-art facilities in this evolving landscape of healthcare is a testament to the commitment provided by the sector to support the advancement of patient care.

Future Market Scenario (2024-2031F)

According to the global endoluminal suturing devices market analysis, the market is anticipated to witness significant growth over the forecast period 2024-2031. This growth can be attributed to expanding healthcare sector, rising investments in research and development activities, and increasing prevalence of various health conditions such as gastrointestinal perforations, severe acid reflux, inflammatory bowel disease, and gastrointestinal cancer. The increasing collaborations between healthcare providers and medical device manufacturers will drive innovation, supporting the development of advanced endoluminal devices and boosting the expansion of the market.

Key Players Landscape and Outlook

The key players of the endoluminal suturing devices market include Apollo Endosurgery, Inc. (Boston Scientific Corporation), B. Braun SE, Medtronic plc, Johnson & Johnson, and Cook Medical. The expansion of the market is supported by increasing investments in research and development activities, collaborations, and successful mergers and acquisitions.

In 2023, Boston Scientific successfully completed the acquisition of Apollo Endosurgery. Apollo's product portfolio includes different devices required in endoluminal surgery procedures. The endoluminal surgery procedures aid in managing gastrointestinal complications and close gastrointestinal defects. These procedures are also employed due to their less-invasive nature as opposed to laparoscopic and open surgeries. With the closure of this acquisition, the companies aim to provide a comprehensive suite of endobariatric and endoluminal surgery solutions to their patients.

Table of Contents

1.Research Methodology

2.Project Scope and Definitions

3.Executive Summary

4.Global Endoluminal Suturing Devices Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product
    • 4.2.1.Endovascular Suturing Devices
    • 4.2.2.Endoscopic Suturing Devices
    • 4.2.3.Consumables
  • 4.3.By Component
    • 4.3.1.Cannula
    • 4.3.2.Needle
    • 4.3.3.Suction Port
  • 4.4.By Application
    • 4.4.1.Gastrointestinal Surgery
    • 4.4.2.Bariatric Surgery
    • 4.4.3.Gastroesophageal Reflux Disease
    • 4.4.4.Thoracic Procedures
    • 4.4.5.Urological Procedures
    • 4.4.6.Others
  • 4.5.By End-User
    • 4.5.1.Hospitals
    • 4.5.2.Ambulatory Surgical Centers
    • 4.5.3.Clinics
    • 4.5.4.Others
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.South America
    • 4.6.3.Europe
    • 4.6.4.Asia-Pacific
    • 4.6.5.Middle East and Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Endoluminal Suturing Devices Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product
      • 5.1.2.1.Endovascular Suturing Devices
      • 5.1.2.2.Endoscopic Suturing Devices
      • 5.1.2.3.Consumables
    • 5.1.3.By Component
      • 5.1.3.1.Cannula
      • 5.1.3.2.Needle
      • 5.1.3.3.Suction Port
    • 5.1.4.By Application
      • 5.1.4.1.Gastrointestinal Surgery
      • 5.1.4.2.Bariatric Surgery
      • 5.1.4.3.Gastroesophageal Reflux Disease
      • 5.1.4.4.Thoracic Procedures
      • 5.1.4.5.Urological Procedures
      • 5.1.4.6.Others
    • 5.1.5.By End-User
      • 5.1.5.1.Hospitals
      • 5.1.5.2.Ambulatory Surgical Centers
      • 5.1.5.3.Clinics
      • 5.1.5.4.Others
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
        • 5.1.6.1.1.By Value
        • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Product
        • 5.1.6.2.1.Endovascular Suturing Devices
        • 5.1.6.2.2.Endoscopic Suturing Devices
        • 5.1.6.2.3.Consumables
      • 5.1.6.3.By Component
        • 5.1.6.3.1.Cannula
        • 5.1.6.3.2.Needle
        • 5.1.6.3.3.Suction Port
      • 5.1.6.4.By Application
        • 5.1.6.4.1.Gastrointestinal Surgery
        • 5.1.6.4.2.Bariatric Surgery
        • 5.1.6.4.3.Gastroesophageal Reflux Disease
        • 5.1.6.4.4.Thoracic Procedures
        • 5.1.6.4.5.Urological Procedures
        • 5.1.6.4.6.Others
      • 5.1.6.5.By End-User
        • 5.1.6.5.1.Hospitals
        • 5.1.6.5.2.Ambulatory Surgical Centers
        • 5.1.6.5.3.Clinics
        • 5.1.6.5.4.Others
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product
  • 6.2.By Component
  • 6.3.By Application
  • 6.4.By End-User
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Apollo Endosurgery, Inc. (Boston Scientific Corporation)
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.B. Braun SE
  • 13.3.Medtronic plc
  • 13.4.Johnson & Johnson
  • 13.5.Cook Medical
  • 13.6.Endo Tools Therapeutics S.A.
  • 13.7.USGI, Medical, Inc.
  • 13.8.Stryker Corporation
  • 13.9.Ovesco Endoscopy AG
  • 13.10.ErgoSuture

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer